The Role of Medicinal Chemistry in the Discovery of Novel Antiviral Agents
Downloads
Antiviral agents have a unique role in the treatment of infectious diseases and represent a substantial portion of the drug marketplace because of the number of viral infections, the lack of successful vaccines, and the inadequacy of other therapeutic modalities to combat viral infections. Medicinal chemistry reveals a vital role in the modernization and productiveness of this drug development process. Antiviral agents predominantly become the drug of choice for a variety of viral infections, mainly HIV, and influenza, accounting for billions of dollars in revenue. The medicinal chemists have done remarkable work in the design and optimization of diverse chemistry libraries through the various methodologies employed for the identification of small molecules preclinically active in vitro against a variety of viruses. Numerous compounds, consisting of various levels of diversity and primarily aromatic rings, were prepared and evaluated in antiviral biochemical and cellular auxiliary screens.
Viruses result in a variety of human and animal diseases and are generally not treatable by antibiotics. Although a few spectrum antivirals exist, most are narrow spectrum, and resistance to current drugs is a growing problem. The consistent effort to improve chemical therapies has paved the path for medicinally designed antivirals that targets various stages in the viral lifecycle, and a large number of them are rapidly synthesized and genuine in series. The present medication with respect to the design and discovery of antiviral agents, emphasizing the prevailing methodologies and strategies of medicinal chemistry research that have been furnished to enhance the antiviral therapeutic toolbox. Though the prior medication reveals the key role of medicinal chemistry in the design and discovery of antiviral agents from different aspects, considerable challenges persist to disturb the current antiviral research and development. Further advance in a variety of aspects ranging from cooperative approaches to advancements in methodology and technology continue to fuel inclusive discovery and progress in this area.
Y. Ma, E. Frutos-Beltrán, and D. Kang, "Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses," Chemical Society, 2021. kuleuven.be
B. C. Gonçalves, M. G. Lopes Barbosa, "Antiviral therapies: advances and perspectives," Fundamental & …, 2021. nih.gov
M. Denel-Bobrowska and A. B. Olejniczak, "Non-nucleoside structured compounds with antiviral activity—past 10 years (2010–2020)," 2022. ncbi.nlm.nih.gov
S. Kausar and F. Said Khan, "A review: Mechanism of action of antiviral drugs," International Journal, 2021. sagepub.com
P. D. Rakowska, M. Tiddia, N. Faruqui, and C. Bankier, "Antiviral surfaces and coatings and their mechanisms of action," Communications, 2021. nature.com
MR Islam, MJ Hossain, and A. Roy, "Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: a rapid review on comparative benefits and risks," Health science, 2022. wiley.com
T. Aravazhi, "Design, Synthesis and In vitro Antioxidant, Antitumor and Antimicrobial activity of Some Novel 2,3-disubstituted quinazoline-4(3H)-One Derivatives.," 2012. [PDF]
R. Elavarasi, "Molecular Design, Synthesis, Characterization and Biological Evaluation of 1-Substituted Tetrahydropyrimidine Derivatives by Leuckart Reaction.," 2014. [PDF]
Y. Han, K. Xing, J. Zhang, T. Tong, Y. Shi, and H. Cao, "Application of sulfoximines in medicinal chemistry from 2013 to 2020," *Journal of Medicinal Chemistry*, 2021. [HTML]
MR Bauer, P Di Fruscia, SCC Lucas, "Put a ring on it: application of small aliphatic rings in medicinal chemistry," Medicinal Chemistry, 2021. nih.gov
T. M. Magne, T. de Oliveira Vieira, L. M. R. Alencar, "Graphene and its derivatives: understanding the main chemical and medicinal chemistry roles for biomedical applications," in *Chemistry*, Springer, 2022. springer.com
I. Diakou, E. Papakonstantinou, L. Papageorgiou, K. Pierouli et al., "Novel computational pipelines in antiviral structure‑based drug design (Review)," 2022. ncbi.nlm.nih.gov
W. Zafar, S. H. Sumrra, and Z. H. Chohan, "A review: Pharmacological aspects of metal based 1, 2, 4-triazole derived Schiff bases," European journal of medicinal chemistry, 2021. [HTML]
R. J. Grams, W. L. Santos, and I. R. Scorei, "The rise of boron-containing compounds: advancements in synthesis, medicinal chemistry, and emerging pharmacology," Chemical, 2024. [HTML]
A. Singh, D. Malhotra, K. Singh, and R. Chadha, "Thiazole derivatives in medicinal chemistry: Recent advancements in synthetic strategies, structure activity relationship and pharmacological outcomes," Journal of Molecular, 2022. [HTML]
D. Chattopadhyay, M. Chawla- Sarkar, T. Chatterjee, R. Sharma Dey et al., "Recent advancements for the evaluation of anti-viral activities of natural products," 2009. ncbi.nlm.nih.gov
B. Müller and H. G. Kräusslich, "Antiviral Strategies," 2009. ncbi.nlm.nih.gov
S. Slagman and W. D. Fessner, "Biocatalytic routes to anti-viral agents and their synthetic intermediates," Chemical Society Reviews, 2021. rsc.org
M. Mei and X. Tan, "Current strategies of antiviral drug discovery for COVID-19," Frontiers in Molecular Biosciences, 2021. frontiersin.org
J. Trivedi, M. Mohan, and S. N. Byrareddy, "Drug Repurposing Approaches to Combating Viral Infections," 2020. ncbi.nlm.nih.gov
M. V. Putz, C. Duda-Seiman, D. Duda-Seiman, A. M. Putz et al., "Chemical Structure-Biological Activity Models for Pharmacophores’ 3D-Interactions," 2016. ncbi.nlm.nih.gov
A. A Nikitina, A. A Orlov, L. I Kozlovskaya, V. A Palyulin et al., "Enhanced taxonomy annotation of antiviral activity data from ChEMBL," 2019. ncbi.nlm.nih.gov
L. G. Ferreira, R. N. dos Santos, G. Oliva, and A. D. Andricopulo, "Molecular Docking and Structure-Based Drug Design Strategies," 2015. ncbi.nlm.nih.gov
H. Zhu, Y. Zhang, W. Li, and N. Huang, "A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years," 2022. ncbi.nlm.nih.gov
K. A. El Sayed, "Natural Products as Antiviral Agents," 2000. ncbi.nlm.nih.gov
A. L. Liu and G. H. Du, "Antiviral Properties of Phytochemicals," 2012. ncbi.nlm.nih.gov
J. Randal Brown, "The Design and Synthesis of Novel Antimicrobial Agents for Use in the Battle Against Bacterial Resistance," 2010. [PDF]
T. Flood, "Advances in high-throughput screening: better compounds, novel targets, enhanced sensors," 2013. [PDF]
G. Li and E. De Clercq, "Current therapy for chronic hepatitis C: The role of direct-acting antivirals," 2017. ncbi.nlm.nih.gov
B. G Roy, "Potential of small-molecule fungal metabolites in antiviral chemotherapy," 2017. ncbi.nlm.nih.gov

